alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of Alliance Financial Corporation (Alliance) for the quarter ended
March 31, 2010 as filed with the Securities and Exchange Commission on the date hereof (the Report), I, J. Daniel Mohr, Executive Vice President and Chief Financial Officer of Alliance, certify, pursuant to 18 U.S.C.
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended;
and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and
results of operations of Alliance.



|                   |  |                                                                                                                 
|------------------ |  | ----------------------------------------------------------------------------------------------------------------
|Dated: May 7, 2010 |  |                                                                                                                 
|                   | 
|                   |  | /s/ J. Daniel Mohr                                                                                              
|                   |  | J. Daniel Mohr Executive
Vice President and Chief Financial Officer (Principal Financial and Accounting Officer)

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the
signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission
or its staff upon request.
<TABLE> <S> <C>

<PAGE>
 
<ARTICLE> 5
<RESTATED>
<CIK>  0000902056
<NAME> SAF T LOK INCORPORATED
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-START>                             JAN-01-1996
<PERIOD-END>                               MAR-31-1996
<CASH>                                          30,149
<SECURITIES>                                 1,735,864
<RECEIVABLES>                                   28,337
<ALLOWANCES>                                         0
<INVENTORY>                                    397,779
<CURRENT-ASSETS>                             2,202,865
<PP&E>                                       1,310,452
<DEPRECIATION>                                 442,481
<TOTAL-ASSETS>                               3,362,457
<CURRENT-LIABILITIES>                          199,382
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                     8,089,270
<OTHER-SE>                                           0
<TOTAL-LIABILITY-AND-EQUITY>                 3,362,457
<SALES>                                         80,648
<TOTAL-REVENUES>                                93,090
<CGS>                                           67,572
<TOTAL-COSTS>                                  531,664
<OTHER-EXPENSES>                                24,322
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                              (530,468)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                          (530,468)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 (530,468)
<EPS-PRIMARY>                                    (.11)<F1>
<EPS-DILUTED>                                    (.07)<F1>
<FN>
<F1>Restated to conform to SFAS No. 128. "EPS-Primary"
denotes Basic EPS.
</FN>
        

</TABLE>
#### § 602.6 FOIA exemptions.

The FOIA allows agencies to withhold documents in certain categories. For instance, we do not have to give you documents that relate to our examination of institutions or that would violate the personal privacy of an individual. If we do not give you a document because the FOIA does not require us to, we will tell you which FOIA exemption applies to our decision.
Editorial Note on Part 45
Editorial Note: Nomenclature changes to part 45 appear at 80 FR 74898, 74910, Nov. 30, 2015.

§ 45.4 Variation margin. ( a ) *General.* After the date on which a covered swap entity enters into a non-cleared swap or non-cleared security-based swap with a swap entity or financial end user, the covered swap entity shall collect variation margin equal to the variation margin amount from the counterparty to such non-cleared swap or non-cleared security-based swap when the amount is positive and post variation margin equal to the variation margin amount to the counterparty to such non-cleared swap or non-cleared security-based swap when the amount is negative.
( b ) *Timing.* A covered swap entity shall comply with the variation margin requirements described in paragraph (a) of this section on each business day, for a period beginning on or before the business day following the day of execution and ending on the date the non-cleared swap or non-cleared security based swap terminates or expires.
( c ) *Other counterparties.* A covered swap entity is not required to collect or post variation margin with respect to any non-cleared swap or non-cleared security-based swap described in § 45.1(d). For any other non-cleared swap or non-cleared security-based swap between a covered swap entity and a counterparty that is neither a financial end user nor a swap entity, the covered swap entity shall collect variation margin at such times and in such forms and such amounts (if any), that the covered swap entity determines appropriately addresses the credit risk posed by the counterparty and the risks of such non-cleared swap or non-cleared security-based swap.
§ 701.35 Share, share draft, and share certificate accounts. ( a ) Federal credit unions may offer share, share draft, and share certificate accounts in accordance with section 107(6) of the Act (12 U.S.C. 1757(6)) and the board of directors may declare dividends on such accounts as provided in section 117 of the Act (12 U.S.C. 1763).
( b ) A Federal credit union shall accurately represent the terms and conditions of its share, share draft, and share certificate accounts in all advertising, disclosures, or agreements, whether written or oral
( c ) A Federal credit union may, consistent with this section, parts 707 and 740 of this subchapter, other federal law, and its contractual obligations, determine the types of fees or charges and other matters affecting the opening, maintaining and closing of a share, share draft or share certificate account. State laws regulating such activities are not applicable to federal credit unions.
( d ) For purposes of this section, “state law” means the constitution, statutes, regulations, and judicial decisions of any state, the District of Columbia, the several territories and possessions of the United States, and the Commonwealth of Puerto Rico.
[47 FR 17979, Apr. 27, 1982, as amended at 50 FR 4637, Feb. 1, 1985; 58 FR 50445, Sept. 27, 1993]
```

[Federal Register Volume 77, Number 102 (Friday, May 25, 2012)]
[Notices]
[Page 31355]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-12774]

-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

[EPA-HQ-OPP-2005-0163; FRL-9351-4]

Aldicarb; Cancellation Order for Amendments To Terminate Uses; 
Correction

AGENCY: Environmental Protection Agency (EPA).

ACTION: Notice; correction.

-----------------------------------------------------------------------

SUMMARY: EPA issued a notice in the Federal Register of May 9, 2012, 
concerning an amendment to terminate uses of aldicarb. This document is 
being issued to correct a typographical error.

FOR FURTHER INFORMATION CONTACT: Susan Bartow, Pesticide Re-evaluation 
Division (7508P), Office of Pesticide Programs, Environmental 
Protection Agency, 1200 Pennsylvania Ave. NW., Washington, DC 20460-
0001; telephone number: (703) 603-0065; email address: 
bartow.susan@epa.gov.

SUPPLEMENTARY INFORMATION:

I. General Information

A. Does this action apply to me?

    The Agency included in the notice a list of those who may be 
potentially affected by this action. If you have questions regarding 
the applicability of this action to a particular entity, consult the 
person listed under FOR FURTHER INFORMATION CONTACT.

B. How can I get copies of this document and other related information?

    EPA has established a docket for this action under docket 
identification (ID) number EPA-HQ-OPP-2005-0163. Publicly available 
docket materials are available either in the electronic docket at 
http://www.regulations.gov, or, if only available in hard copy, at the 
Office of Pesticide Programs (OPP) Regulatory Public Docket in Rm. S-
4400, One Potomac Yard (South Bldg.), 2777 S. Crystal Dr., Arlington, 
VA. The hours of operation of this Docket Facility are from 8:30 a.m. 
to 4 p.m., Monday through Friday, excluding legal holidays. The Docket 
Facility telephone number is (703) 305-5805.

II. What does this correction do?

    The preamble for FR Doc. 2012-11072 published in the Federal 
Register of May 9, 2012 (77 FR 27226) (FRL-9348-2) is corrected as 
follows: On page 27227, first column of Table 1, under the heading EPA 
Registration Number, correct 264-333 to read 264-330.

List of Subjects

    Environmental protection, pesticides and pests.

    Dated: May 17, 2012.
Richard P. Keigwin, Jr.,
Director, Pesticide Re-evaluation Division, Office of Pesticide 
Programs.
[FR Doc. 2012-12774 Filed 5-24-12; 8:45 am]
BILLING CODE 6560-50-P
```
§ 7.1023 Federal savings associations, prohibition on industrial or commercial metal dealing or investing. ( a ) In this section, *industrial or commercial metal* means metal (including an alloy) in a physical form primarily suited to industrial or commercial use, for example, copper cathodes.
( b ) Federal savings associations may not deal or invest in industrial or commercial metal.
( c ) *Other authorities not affected.* This section may not be construed to preclude a Federal savings association from acquiring or selling metal in connection with its authority to foreclose on loan collateral, compromise doubtful claims, or avoid loss in connection with a debt previously contracted.
( d ) *Nonconforming holdings.* Federal savings associations that hold industrial or commercial metal as a result of dealing or investing in that metal must dispose of such metal as soon as practicable, but not later than one year from April 1, 2018. The OCC may grant up to four separate one-year extensions to dispose of industrial or commercial metal if a Federal savings association makes a good faith effort to dispose of the metal and retention of the metal for an additional year is not inconsistent with safe and sound operation of the association.
[81 FR 96360, Dec. 30, 2016, as amended at 85 FR 83729, Dec. 22, 2020]
###### Editorial Note on Part 725

#### Editorial Note:

Nomenclature changes to part 725 appear at 84 FR 1608, Feb. 5, 2019.

#### §§ 725.8-725.16 [Reserved]
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

                    Notice is hereby given of a change in the meeting of the Center for Scientific Review Special Emphasis Panel, November 5, 2009, 8 a.m. to November 6, 2009, 5:00 PM, Hotel Nikko San Francisco, 222 Mason Street, San Francisco, CA, 94102 which was published in the                     **Federal Register**                     on October 2, 2009, 74 FR 50975-50977.                

The meeting title has been changed to “Fellowship: Cell Biology and Development”. The meeting is closed to the public.

Dated: October 9, 2009.

Jennifer Spaeth,

Director, Office of Federal Advisory Committee Policy.

[FR Doc. E9-24975 Filed 10-15-09; 8:45 am]

BILLING CODE 4140-01-P
<PAGE>

                            EXHIBIT 11 TO FORM 10-KSB

COMPUTATION OF EARNINGS PER COMMON SHARE AND COMMON SHARE EQUIVALENTS

<TABLE>
<CAPTION>
                                                           Year Ended December 31,
                                                      -----------------------------------
                                                           2000                1999
                                                      ----------------    ---------------
<S>                                                   <C>                 <C>
BASIC EARNINGS PER SHARE
Weighted average common shares outstanding ............     18,877,192      16,612,314
                                                          ============    ============
    Basic loss before extraordinary gain ..............   $      (0.46)   $      (0.62)
                                                          ============    ============
    Basic loss per share ..............................   $      (0.40)   $      (0.62)
                                                          ============    ============

DILUTED EARNINGS PER SHARE
Weighted average common shares outstanding ............     18,877,192      16,612,314
Shares issuable from assumed conversion of
       Convertible preferred stock ....................        259,458          96,830
Shares issuable from assumed conversion of
    common share options and warrants .................        507,459          10,437
                                                          ------------    ------------
Weighted average common shares outstanding, as adjusted     19,644,109      16,719,581
                                                          ============    ============
    Diluted loss before extraordinary gain ............   $      (0.44)   $      (0.61)
                                                          ============    ============
    Diluted loss per share ............................   $      (0.38)   $      (0.61)
                                                          ============    ============

EARNINGS FOR BASIC AND DILUTED COMPUTATION
Net loss before extraordinary gain ....................   $ (8,660,638)   $(10,250,238)
Extraordinary gain ....................................      1,126,034             ---
                                                          ------------    ------------
Net loss to common shareholders (basic and diluted
    earnings per share computation) ...................   $ (7,534,604)   $(10,250,238)
                                                          ============    ============
</TABLE>

This calculation is submitted in accordance with Regulation S-K; although it
is contrary to paragraphs 13 through 16 of the Financial Accounting Standards
Board's Statement of Financial Standard No. 128, because it produces an
antidilutive result.
<TABLE> <S> <C>

<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-START>                             JUL-01-1997
<PERIOD-END>                               SEP-30-1997
<CASH>                                          27,872
<SECURITIES>                                         0
<RECEIVABLES>                                  400,012
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                               489,016
<PP&E>                                         125,161
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                 614,177
<CURRENT-LIABILITIES>                          425,000
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                     4,934,689
<OTHER-SE>                                  (5,112,318)
<TOTAL-LIABILITY-AND-EQUITY>                   614,177
<SALES>                                         45,327
<TOTAL-REVENUES>                                45,327
<CGS>                                                0
<TOTAL-COSTS>                                  513,079
<OTHER-EXPENSES>                                 7,032
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                               (474,784)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   474,711
<EPS-PRIMARY>                                   (0.012)
<EPS-DILUTED>                                        0
        

</TABLE>
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
COMPANY'S STATEMENTS OF EARNINGS AND BALANCE SHEETS AND IS QUALIFIED IN ITS
ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          JAN-02-2000
<PERIOD-END>                               JAN-02-2000
<CASH>                                               0
<SECURITIES>                                         0
<RECEIVABLES>                                    6,405
<ALLOWANCES>                                        93
<INVENTORY>                                    155,283
<CURRENT-ASSETS>                               163,123
<PP&E>                                          35,557
<DEPRECIATION>                                  32,910
<TOTAL-ASSETS>                                 231,465
<CURRENT-LIABILITIES>                           91,042
<BONDS>                                        151,309
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                    (18,045)
<TOTAL-LIABILITY-AND-EQUITY>                   231,465
<SALES>                                        514,324
<TOTAL-REVENUES>                               514,324
<CGS>                                          341,852
<TOTAL-COSTS>                                  341,852
<OTHER-EXPENSES>                               140,312
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              17,461
<INCOME-PRETAX>                                 14,699
<INCOME-TAX>                                     5,829
<INCOME-CONTINUING>                              8,870
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                  (396)
<CHANGES>                                            0
<NET-INCOME>                                     8,474
<EPS-BASIC>                                        0
<EPS-DILUTED>                                        0


</TABLE>
EXHIBIT 31

                       CERTIFICATION PURSUANT TO SECTION
                         302 OF THE SARBANES OXLEY ACT


I, Blair Zykan, certify that:

1. I have reviewed this quarterly report on Form 10-QSB of TDI Holding Corp.;

2. Based on my  knowledge,  this  quarterly  report  does not contain any untrue
statement of a material fact or omit to state a material fact  necessary to make
the statements made, in light of the  circumstances  under which such statements
were made, not  misleading  with respect to the period covered by this quarterly
report;

3.  Based  on my  knowledge,  the  financial  statements,  and  other  financial
information  included in this quarterly  report,  fairly present in all material
respects the financial  condition,  results of operations  and cash flows of the
registrant as of, and for, the periods presented in this quarterly report;

4.  The  registrant's  other  certifying  officers  and  I are  responsible  for
establishing and maintaining  disclosure  controls and procedures (as defined in
Exchange Act Rules 13a-14 and 15d-14) for the registrant and have:

     a) designed such disclosure controls and procedures to ensure that material
     information   relating  to  the  registrant,   including  its  consolidated
     subsidiaries,  is  made  known  to  us by  others  within  those  entities,
     particularly  during  the period in which  this  quarterly  report is being
     prepared;

     b) evaluated the effectiveness of the registrant's  disclosure controls and
     procedures  as of a date  within 90 days prior to the  filing  date of this
     quarterly report (the "Evaluation Date"); and

     c)  presented  in  this  quarterly   report  our   conclusions   about  the
     effectiveness  of the  disclosure  controls  and  procedures  based  on our
     evaluation as of December 31, 2004;

5. The registrant's other certifying officers and I have disclosed, based on our
most recent evaluation,  to the registrant's auditors and the audit committee of
registrant's   board  of  directors  (or  persons   performing   the  equivalent
functions):

     a) all  significant  deficiencies  in the design or  operation  of internal
     controls which could adversely affect the  registrant's  ability to record,
     process,  summarize and report  financial data and have  identified for the
     registrant's auditors any material weaknesses in internal controls; and

<PAGE>

     b) any fraud,  whether or not material,  that involves  management or other
     employees  who  have  a  significant  role  in  the  registrant's  internal
     controls; and

6. The  registrant's  other  certifying  officers  and I have  indicated in this
quarterly report whether there were significant  changes in internal controls or
in other factors that could significantly affect internal controls subsequent to
the date of our most recent  evaluation,  including any corrective  actions with
regard to significant deficiencies and material weaknesses.

Date:  February 17, 2005


/s/ Blair Zykan
-----------------------
Blair Zykan,
President & CFO